Total Funding
20
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
199969
Anelixis Therapeutics is a biotechnology company that facilitates pre-clinical drug development.
Acquired by 
Eledon Pharmaceuticals
- Walter Ogier: Executive Chairman
- Steve Perrin: CEO
About the Company
Anelixis Therapeutics is a clinical stage development company located in Cambridge, Massachusetts with a portfolio focused on immune modulatory drugs for neurodegenerative diseases with a focus on amyotrophic lateral sclerosis (ALS) and Alzheimer's Disease (AD).
Anelixis Therapeutics is committed to advancing treatments that will have a
meaningful impact on the lives of patients by helping them battle back their disease progression.
